일동제약

249420KOSPI의약품 제조업

43.9 / 100

Reference Date: 2026-06-10

Financial Score12.0 / 40

News Sentiment16.9 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average but the high debt ratio poses financial risk. Plunged 21.3% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Il Dong Pharmaceutical is a company engaged in the manufacture and sale of pharmaceuticals, raw materials, and health supplements. Key products include Aronamin, Furumarin, and Laviert, with sales of 614,941 million won in the 9th fiscal year. Products are distributed domestically and internationally through channels such as wholesale, retail, and hospitals, with active R&D investments.

Number of Employees

1,104people

Average Salary

79.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

19.93Industry Average 11.931.5Point

1.7x industry avg (risky)

PBR

2.48Industry Average 0.890.0Point

2.8x industry avg (risky)

ROE

11.89Industry Average 4.017.0Point

3.0x industry avg (excellent)

Debt Ratio

42.82Industry Average 12.430.0Point

3.4x industry avg (risky)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼2.7% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲86.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -13.0% (improving, 3yr)

Detailed News Sentiment

33 totalPositive 15Neutral 12Negative 6Average Sentiment Score 67.4

Positive
체중감량 넘어 심장·간까지 보호…미국 학회 달군 K-바이오
일동제약 관련 연구가 미국 학회에서 주목받아 기술 수출 기대감 증가.
Positive
일동, 영양제 '아로나민 씨플러스 프리미엄' 출시
일동제약의 신규 프리미엄 영양제 출시로 시장 경쟁력 강화 및 매출 증대 기대.
Neutral
K-바이오, 美 당뇨학회서 ‘비만 연구’ 임상 공개… 근육증진·4중작....
K-바이오 기업들의 ADA 참가로 비만 및 근육 증진 치료제 관련 임상 결과 발표되었으나, 직접적인 영향은 제한적.

Detailed Momentum

52-week position3.0Point

52w lower range (20%)

Current 18,770Won52-week high 44,30052-week low 12,150

1-month return0.0Point

1m -21.30% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral지속가능경영보고서등관련사항(자율공시)2026-06-04
Neutral기업지배구조보고서공시2026-05-29
Neutral분기보고서 (2026.03)2026-05-15
Neutral연결재무제표기준영업(잠정)실적(공정공시)2026-05-13